Over Active Bladder
10
1
1
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.4% vs benchmark
10%
1 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 7 completed trials
Clinical Trials (10)
Autologous Platelet Concentrate Bladder Injection for Refractory Overactive Bladder
Electroacupuncture as a Treatment for Refractory Overactive Bladder
A Prospective Evaluation of a Prescription Digital Therapeutic for Treatment of Overactive Bladder in Women: The RiSolve Trial
Stimulating Percutaneous Array for Urinary Reflex Control (SPARC)
The Effect Of Pelvic Floor Muscle Exercises On Sexual Life In Women With Overactive Bladder
Sacral Neuromodulation With InterStim® Therapy for Intractable Urinary Voiding Dysfunctions (SOUNDS): an Observational Study
BlueWind Medical System for the Treatment of Patients With OAB
Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder
A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment
Lessening Incontinence by Learning Yoga